date:Dec 21, 2012
s for the company.
The globally recognized know-how of Symrise in sensory, active ingredients and applications combined with Probis long-standing and proprietary expertise in patented probiotics will allow us to develop new consumer products with real health benefits and sensory profiles without compromises, added Michael Oredsson, CEO of Probi AB.
Symrise AG currently holds a 14.97% minority share of Probi and may increase this stake in the future. The company is listed on the NASDAQ OMX Nord